FDA rebukes Pfizer CEO’s suggestion to take more Paxlovid if COVID-19 symptoms return

FDA rebukes Pfizer CEO’s suggestion to take more Paxlovid if COVID-19 symptoms return

Source: 
Fierce Pharma
snippet: 

The FDA rebuked Pfizer CEO Albert Bourla’s proposed solution to reports that some patients experienced a relapse of COVID-19 symptoms after treatment with the company's antiviral Paxlovid.